References

  1. Silvestris F, Cafforio P, Tucci M, Dammacco F. Negative regulation of erythroblast maturation by Fas-L(+)/TRAIL(+) highly malignant plasma cells: a major pathogenetic mechanism of anemia in multiple myeloma. Blood. 2002; 99(4):1305-13. PubMed | Google Scholar

  2. Patel R, Salamassi S. Possible auto-immune hemolysis with multiple myeloma: a case report with review of the literature. Blood. 1987; 70( suppl 1):113a. PubMed | Google Scholar

  3. Vaiopoulos G, Kyriakou D, Papadaki H, Fessas P, Eliopoulos GD. Multiple myeloma associated with autoimmune hemolytic anemia. Haematologica. 1994; 79(3): 262-4. PubMed | Google Scholar

  4. Sergentanis TN, Zagouri F, Tsilimidos G, Tsagianni A, Tseliou M, Dimopoulos MA, Psaltopoulou T. Risk Factors for Multiple Myeloma: a Systematic review of meta-analyses. Clin Lymphoma Myeloma Leuk. 2015; 15(10): 563-77. PubMed | Google Scholar

  5. Shah BK, Uprety D, Tretheway D. Multiple myeloma presenting with autoimmune hemolytic anemia. Indian J Hematol Blood Transfus. 2014; 30(Suppl 1): 38-9. PubMed | Google Scholar

  6. Benjilali L, Essaadouni L. A multiple myeloma associated with autoimmune hemolytic anemia. Presse Med. 2013; 42(11):1533-5. PubMed | Google Scholar

  7. Mittelman M. The implications of anemia in multiple myeloma. Clin Lymphoma. 2003; 1 (suppl 4): S23-9. PubMed | Google Scholar

  8. Wada H, Yata K, Mikami M, Suemori S, Nakanishi H, Kondo T, Tsujioka T, Suetsugu Y, Otsuki T, Sadahira Y, Yawata Y, Sugihara T. Multiple myeloma complicated by autoimmune hemolytic anemia. Intern Med. 2004; 43(7): 595-8. PubMed | Google Scholar

  9. Gupta V, Hegde UM, Parameswaran R, Newland AC. Multiple myeloma and immune thrombocytopenia. Clin Lab Haematol. 2000; 22(4): 239-42. PubMed | Google Scholar

  10. Cines DB, Liebman H, Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol. 2009; 46(1 Suppl 2): S2-14. PubMed | Google Scholar

  11. Yi Y, Zhang GS, Gong FJ, Yang JJ. Multiple myeloma complicated by Evans syndrome. Intern Med J. 2009; 39(6): 421-2. PubMed | Google Scholar

  12. Kashyap R, Singh A, Kumar P. Prevalence of autoimmune hemolytic anemia in multiple myeloma: a prospective study. Asia Pac J Clin Oncol. 2016; 12(2): e319-22. PubMed | Google Scholar

  13. Darabi K, Kantamnei S, Wiernik PH. Lenalidomide induced warm autoimmune hemolytic anemia. J Clin Oncol. 2006; 24(35): e59. PubMed | Google Scholar

  14. Gesundheit B, Zelig O, Shapira MY, Ackerstein A, Avgil M, Or R. Complete remission of multiple myeloma after autoimmune hemolytic anemia: possible association with interferon-alpha. Am J Hematol. 2007; 82(6): 489-92. PubMed | Google Scholar

  15. Hofer S, Hunziker S, Dirnhofer S, Ludwig C. Rituximab effective in a patient with refractory autoimmune haemolytic anaemia and CD20-negative multiple myeloma. Br J Haematol. 2003; 122(4): 690-1. PubMed | Google Scholar